Underwriters Exercise Full Overallotment in Alnylam (ALNY) Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Alnylam (ALNY) Ticks Higher on Strong Offering Price
January 16, 2013 11:11 AM ESTAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) is ticking higher on volume today following strong pricing of its eight million common stock offering. Shares are up 6.6 percent on Wednesday's session.
The Company said it priced the offering at $20.13 per share, flat with the... More
Alnylam Pharma (ALNY) Announces $125M Common Offering
January 14, 2013 4:04 PM ESTAlnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold... More
